DKDaria N. Kindt

Daria N. Kindt

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Daria N. Kindt has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • HCT116 cell line heterogeneity: A useful tool for preclinical research

    by Tatyana A. Grigoreva, Aleksandra V. Sagaidak, Daria N. Kindt, Anastasiya D. Zenina, Angelina A. Romanova, Gleb S. Ivanov, Tatyana K. Yakovleva, Viktoriya I. Turilova, Vyacheslav G. Tribulovich


  • Open Access

    The Managed Acquisition of Chemoresistance as an Informative Tool for Tumor Research

    by Tatyana A. Grigoreva, Daria N. Kindt, Aleksandra V. Sagaidak, Angelina A. Romanova, Vyacheslav G. Tribulovich

    The problem of acquiring chemoresistance by tumor cells is a growing concern for researchers as the effectiveness of diagnosis and treatment of primary tumors increases. To study the mechanisms of resistance, as well as to evaluate the effectiveness of new drugs, it is necessary to use adequate cell models. The review presents modern methods for obtaining chemoresistant cell lines used by researchers in such studies. It examines the most common cytostatics and targeted drugs, such as cisplatin, oxaliplatin, paclitaxel, doxorubicin, 5-fluorouracil, gemcitabine, gefitinib, bortezomib, erlotinib, and the monoclonal antibody cetuximab. Particular attention is paid to cell mechanisms activated due to drug resistance development and to methods of cell cultivation in the presence of drugs. The presented information provides an opportunity to discuss trends in the creation of chemoresistant cell lines for further research on resistance mechanisms and the development of new therapeutic strategies.


  • Open Access

    Optimization of the Scheme for Decontaminating Continuous Human Cell Cultures with Antibiotics of Different Mechanisms

    by Т. А. Григорьева, A. A. Pozharskii, Y. A. Grigorev, D. N. Kindt, D. S. Novikova

    The absence of contamination is an important condition for the reliability of the results obtained when conducting experiments on cell cultures. At the same time, long-term cultivation significantly increases the risk of contamination of the cellular material, and therefore it is necessary to maintain cellular purity and remove contaminants in the event of contamination. The most common contaminants are bacteria, yeast and fungi, and, in rare cases, viruses and protozoa. Accordingly, to combat biological contamination, it is necessary to use drugs of different mechanisms depending on the nature of the contaminant. The article examines the effect of the most common antibiotic and antimycotic drugs in laboratory practice on the vital activity of continuous adherent human cell cultures. It was shown that different cell cultures have different sensitivity to the drugs used for decontamination, which indicates the need to develop individual treatment regimens for a specific cell line. Safe ranges of drug concentrations were established for lung adenocarcinoma, osteosarcoma, colorectal carcinoma, and human embryonic kidney cells. Taking into account the obtained data, spontaneous contamination was treated in a long-cultivated strain of the H1299 line. Artificial infection of the studied cell lines with the identified contaminant followed by treatment according to a similar scheme confirmed the adequacy of using ciprofloxacin for decontamination of various adherent cultures in laboratory practice.

  • Open Access

    Cellular Systems for Colorectal Stem Cancer Cell Research

    by Tatyana A. Grigoreva, Daria N. Kindt, Aleksandra V. Sagaidak, Daria S. Novikova, Vyacheslav G. Tribulovich

    Oncological diseases consistently occupy leading positions among the most life-threatening diseases, including in highly developed countries. At the same time, the second most common cause of cancer death is colorectal cancer. The current level of research shows that the development of effective therapy, in this case, requires a new grade of understanding processes during the emergence and development of a tumor. In particular, the concept of cancer stem cells that ensure the survival of chemoresistant cells capable of giving rise to new tumors is becoming widespread. To provide adequate conditions that reproduce natural processes typical for tumor development, approaches based on increasingly complex cellular systems are being improved. This review discusses the main strategies that allow for the study of the properties of tumor cells with an emphasis on colorectal cancer stem cells. The features of working with tumor cells and the advantages and disadvantages of 2D and 3D culture systems are considered.